These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38089042)

  • 21. Determination of the localization of gangliosides using anti-ganglioside antibodies: comparison of fixation methods.
    Schwarz A; Futerman AH
    J Histochem Cytochem; 1997 Apr; 45(4):611-8. PubMed ID: 9111239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
    Ravindranath MH; Morton DL; Irie RF
    Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of gangliosides in active immunotherapy with melanoma vaccine.
    Ravindranath MH; Morton DL
    Int Rev Immunol; 1991; 7(4):303-29. PubMed ID: 1779175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium-ganglioside interactions and synaptic plasticity: effect of calcium on specific ganglioside/peptide (valinomycin, gramicidin A)-complexes in mixed mono- and bilayers.
    Rahmann H; Schifferer F; Beitinger H
    Neurochem Int; 1992 Apr; 20(3):323-38. PubMed ID: 1284679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.
    Plomp JJ; Willison HJ
    J Physiol; 2009 Aug; 587(Pt 16):3979-99. PubMed ID: 19564393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP).
    Estevez F; Carr A; Solorzano L; Valiente O; Mesa C; Barroso O; Sierra GV; Fernandez LE
    Vaccine; 1999 Aug; 18(1-2):190-7. PubMed ID: 10501249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganglioside Profiling of the Human Retina: Comparison with Other Ocular Structures, Brain and Plasma Reveals Tissue Specificities.
    Sibille E; Berdeaux O; Martine L; Bron AM; Creuzot-Garcher CP; He Z; Thuret G; Bretillon L; Masson EA
    PLoS One; 2016; 11(12):e0168794. PubMed ID: 27997589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gangliosides and cancer].
    Dumontet C; Portoukalian J
    Bull Cancer; 1991; 78(9):789-99. PubMed ID: 1751830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the Analysis of Gangliosides by LC-MS.
    Muggli T; Bühr C; Schürch S
    Chimia (Aarau); 2022 Feb; 76(1-2):109-113. PubMed ID: 38069756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization.
    Fabris D; Rožman M; Sajko T; Vukelić Ž
    Biochimie; 2017 Jun; 137():56-68. PubMed ID: 28286312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ganglioside GD2 in reception and transduction of cell death signal in tumor cells.
    Doronin II; Vishnyakova PA; Kholodenko IV; Ponomarev ED; Ryazantsev DY; Molotkovskaya IM; Kholodenko RV
    BMC Cancer; 2014 Apr; 14():295. PubMed ID: 24773917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
    Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
    Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy.
    Groux-Degroote S; Delannoy P
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renewed synthetic approach to gangliosides exploiting versatile and powerful synthetic units.
    Ando H; Ishida H; Kiso M
    Methods Enzymol; 2010; 478():521-40. PubMed ID: 20816497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients.
    Yu J; Wu X; Yan J; Yu H; Xu L; Chi Z; Sheng X; Si L; Cui C; Dai J; Ma M; Xu T; Kong Y; Guo J
    J Hematol Oncol; 2018 Jan; 11(1):1. PubMed ID: 29298689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression analysis of 0-series gangliosides in human cancer cell lines with monoclonal antibodies generated using knockout mice of ganglioside synthase genes.
    Bhuiyan RH; Kondo Y; Yamaguchi T; Tokuda N; Ohkawa Y; Hashimoto N; Ohmi Y; Yamauchi Y; Furukawa K; Okajima T; Furukawa K
    Glycobiology; 2016 Sep; 26(9):984-998. PubMed ID: 27102283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer.
    Distler U; Souady J; Hülsewig M; Drmić-Hofman I; Haier J; Denz A; Grützmann R; Pilarsky C; Senninger N; Dreisewerd K; Berkenkamp S; Schmidt MA; Peter-Katalinic J; Müthing J
    Mol Cancer Ther; 2008 Aug; 7(8):2464-75. PubMed ID: 18723492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gangliosides of the Nervous System.
    Ledeen R; Wu G
    Methods Mol Biol; 2018; 1804():19-55. PubMed ID: 29926403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.
    Asthana P; Vong JS; Kumar G; Chang RC; Zhang G; Sheikh KA; Ma CH
    Mol Neurobiol; 2016 Sep; 53(7):4981-91. PubMed ID: 26374552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very low density lipoproteins and interleukin 2 enhance the immunogenicity of 9-O-acetyl-GD3 ganglioside in BALB/c mice.
    Dumontet C; Rebbaa A; Portoukalian J
    J Immunol Methods; 1997 Aug; 206(1-2):115-23. PubMed ID: 9328574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.